Delivery Order SPE2DB20D3303-SPE2DB25FA1RR
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.77 firm fixed-price delivery order is for the supply of 4,566,894 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 13, 2025 and is not designated under any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,576.34 firm-fixed-price delivery order is for the supply of 4,558,762,323 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has an ultimate completion date of October 14, 2022 and does not include any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.51 firm fixed-price delivery order is for the supply of 4,562,296,296 units of pantoprazole sodium delayed-release 40 mg tablets. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,725.94 firm-fixed-price delivery order is for the supply of 4,567,666,818 units of Pantoprazole Sodium Delayed-Release 40mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,187,922 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The firm fixed-price contract, valued at $2,008.44, has an ultimate completion date of October 24, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization, is the prime contractor with no major...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in 1,000-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,495.89, and has an ultimate completion date of September 12, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, will provide these...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,841.28, is for the supply of 4,562,828,860 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a period of performance through November 16, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA...
- This contract award, valued at $2,931.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pantoprazole sodium delayed-release 40 mg tablets. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a comprehensive contracting vehicle for the DLA to procure a wide range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count bottles, with a ceiling value of $1,356.74 and a completion date of June 21, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,515.78 firm fixed-price delivery order is for the supply of 4,564,327,287 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of April 19, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1RRDelivery Order
This delivery order, awarded on July 23, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg under a firm fixed-price contract valued at $5,474.50. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. This IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order is non-set-aside and was competitively awarded, with performance expected to conclude by July 24, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company demonstrates extensive capability in fulfilling federal medical supply needs through its diverse portfolio of delivery orders with the DLA, ranging from routine pharmaceutical supplies to specialized medical commodities. As a registered System for Award Management (SAM.gov) vendor, AmerisourceBergen operates as a for-profit organization and maintains significant contracts across multiple therapeutic domains, positioning it as a key component of the military's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/23/25 |